News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Aldagen, Inc. Files for $80.5 Million IPO
May 12, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, May 9 (Reuters) - Biopharmaceutical company Aldagen Inc filed with regulators on Friday to raise up to $80.5 million in an initial public offering of common stock.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Podcast
J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer
April 15, 2026
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Lilly wants to bridge cancer care gap with $300M ADC biotech buy
April 14, 2026
·
1 min read
·
Gabrielle Masson
IPO
Kailera eyes record $533M+ IPO to play in competitive obesity space with Chinese drugs
April 14, 2026
·
2 min read
·
Tristan Manalac
Pain
AbbVie enters world of pain in up to $715M deal with China’s Haisco
April 13, 2026
·
1 min read
·
Annalee Armstrong
